$1.93
0.063.21%
At close: -
$1.88
-0.05-2.59%
After Hours: 4:57 PM EDT
Sutro Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sutro Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $-0.59 | $-0.73 | 19.2 % |
Jun 2024 | 2024-08-13 | $-0.59 | $-0.79 | 25.3 % |
Mar 2024 | 2024-05-13 | $-0.95 | $-0.86 | -10.5 % |
Dec 2023 | 2024-03-25 | $0.52 | $-0.82 | 163.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $8.52M | $15.25M | -44.1 % |
Jun 2024 | 2024-08-13 | $25.71M | $21.02M | 22.3 % |
Mar 2024 | 2024-05-13 | $13.01M | $11.97M | 8.67 % |
Dec 2023 | 2024-03-25 | $113.72M | $11.81M | 862.9 % |
Sutro Biopharma (STRO) is scheduled to report earnings on March 24, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.59, which beat the estimate of $-0.73.
The Actual Revenue was $8.5M, which missed the estimate of $15.3M.
Browse earnings estimates, EPS, and revenue on all stocks.